PDE4B and immune system disorder: Studies from Chinese researchers utilizing single-cell sequencing and genome-wide association analyses have revealed that cAMP signaling deficiency leads to immune dysfunction, and that PDE4B inhibition by dipyridamole demonstrates therapeutic potential in animal models (23).